Corrections needed to 2016 ESC and AHA guidelines on heart failure.
Publication
, Journal Article
Rydén, L; Van de Werf, F; Armstrong, PW; McGuire, DK; Standl, E; Peterson, ED; Holman, RR
Published in: Lancet Diabetes Endocrinol
May 2017
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Lancet Diabetes Endocrinol
DOI
EISSN
2213-8595
Publication Date
May 2017
Volume
5
Issue
5
Start / End Page
325 / 326
Location
England
Related Subject Headings
- Incretins
- Hypoglycemic Agents
- Humans
- Heart Failure
- Guidelines as Topic
- Dipeptidyl-Peptidase IV Inhibitors
- 3205 Medical biochemistry and metabolomics
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Rydén, L., Van de Werf, F., Armstrong, P. W., McGuire, D. K., Standl, E., Peterson, E. D., & Holman, R. R. (2017). Corrections needed to 2016 ESC and AHA guidelines on heart failure. Lancet Diabetes Endocrinol, 5(5), 325–326. https://doi.org/10.1016/S2213-8587(17)30102-X
Rydén, Lars, Frans Van de Werf, Paul W. Armstrong, Darren K. McGuire, Eberhard Standl, Eric D. Peterson, and Rury R. Holman. “Corrections needed to 2016 ESC and AHA guidelines on heart failure.” Lancet Diabetes Endocrinol 5, no. 5 (May 2017): 325–26. https://doi.org/10.1016/S2213-8587(17)30102-X.
Rydén L, Van de Werf F, Armstrong PW, McGuire DK, Standl E, Peterson ED, et al. Corrections needed to 2016 ESC and AHA guidelines on heart failure. Lancet Diabetes Endocrinol. 2017 May;5(5):325–6.
Rydén, Lars, et al. “Corrections needed to 2016 ESC and AHA guidelines on heart failure.” Lancet Diabetes Endocrinol, vol. 5, no. 5, May 2017, pp. 325–26. Pubmed, doi:10.1016/S2213-8587(17)30102-X.
Rydén L, Van de Werf F, Armstrong PW, McGuire DK, Standl E, Peterson ED, Holman RR. Corrections needed to 2016 ESC and AHA guidelines on heart failure. Lancet Diabetes Endocrinol. 2017 May;5(5):325–326.
Published In
Lancet Diabetes Endocrinol
DOI
EISSN
2213-8595
Publication Date
May 2017
Volume
5
Issue
5
Start / End Page
325 / 326
Location
England
Related Subject Headings
- Incretins
- Hypoglycemic Agents
- Humans
- Heart Failure
- Guidelines as Topic
- Dipeptidyl-Peptidase IV Inhibitors
- 3205 Medical biochemistry and metabolomics
- 3202 Clinical sciences
- 1117 Public Health and Health Services
- 1103 Clinical Sciences